The aim of this review is to evaluate emerging targeted interventions to modulate AREG-mediated molecular pathways in fibrotic processes observed in autoimmune diseases, starting with the structure of AREG and the molecular mechanisms in which the protein is involved. Here, AREG is linked to autoimmune disease.